Could Risk Stratifying MTX Users Lead to Testing Less Often?

A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical application, experts say.
Medscape Medical News

source https://www.medscape.com/viewarticle/994926?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost